Literature DB >> 24306515

Attitudes and knowledge of medical practitioners to hereditary cancer clinics and cancer genetic testing.

Ian Teng1, Allan Spigelman.   

Abstract

Genetic testing for susceptibility for common cancers is widely available. Thus, doctors have a role in identifying and referring patients who would benefit from a consultation with a specialist in genetics. This study aims to assess doctors' referral rates, knowledge and attitudes towards cancer genetic testing, broken down by specialty (gastrointestinal, breast/ovarian, other specialties and General Practitioners-GPs). A 4-page questionnaire was mailed out to the GPs of all patients seen in 2012 in the Hereditary Cancer Clinic of St. Vincent's Hospital Sydney (n = 128) and all the specialists in St. Vincent's Hospital Sydney that might refer to the HCC (n = 33). 50 questionnaires were returned (31 %). Most doctors had referred a patient for cancer genetic testing (90 %). The average proportion of patients referred was 1 in 68.5 patients with breast/ovarian specialists referring the most, followed by gastrointestinal specialists and GPs. There was suboptimal knowledge of cancer genetic testing amongst doctors. Breast/ovarian specialists were most knowledgeable, followed by gastrointestinal specialists, other specialists and GPs. There were indications of inappropriate referral amongst doctors. Most (77.6 %) doctors were willing to receive further information on cancer genetics. Nearly all (94 %) doctors believe that it is their duty to inform an individual at high risk for hereditary cancer that cancer genetic counselling and testing is available. The majority of doctors have positive attitudes towards cancer genetic testing. Defective knowledge scores, however, indicate that doctors need further training or tools to enable them to refer patients appropriately for cancer genetic testing.

Entities:  

Mesh:

Year:  2014        PMID: 24306515     DOI: 10.1007/s10689-013-9695-y

Source DB:  PubMed          Journal:  Fam Cancer        ISSN: 1389-9600            Impact factor:   2.375


  19 in total

1.  Genetic testing in New Zealand: the role of the general practitioner.

Authors:  Sonya Morgan; Deborah McLeod; Alexa Kidd; Barbara Langford
Journal:  N Z Med J       Date:  2004-11-26

2.  Reported referral for genetic counseling or BRCA 1/2 testing among United States physicians: a vignette-based study.

Authors:  Katrina F Trivers; Laura-Mae Baldwin; Jacqueline W Miller; Barbara Matthews; C Holly A Andrilla; Denise M Lishner; Barbara A Goff
Journal:  Cancer       Date:  2011-07-25       Impact factor: 6.860

3.  Hereditary breast/ovarian and colorectal cancer genetics knowledge in a national sample of US physicians.

Authors:  L Wideroff; S T Vadaparampil; M H Greene; S Taplin; L Olson; A N Freedman
Journal:  J Med Genet       Date:  2005-03-22       Impact factor: 6.318

4.  Primary care physicians' knowledge and attitudes towards genetic testing for breast-ovarian cancer predisposition.

Authors:  M Escher; A P Sappino
Journal:  Ann Oncol       Date:  2000-09       Impact factor: 32.976

5.  Are physician recommendations for BRCA1/2 testing in patients with breast cancer appropriate? A population-based study.

Authors:  Anne Marie McCarthy; Mirar Bristol; Tracey Fredricks; Lache Wilkins; Irene Roelfsema; Kaijun Liao; Judy A Shea; Peter Groeneveld; Susan M Domchek; Katrina Armstrong
Journal:  Cancer       Date:  2013-07-16       Impact factor: 6.860

Review 6.  Recent advances in colorectal cancer genetics and diagnostics.

Authors:  Peh Yean Cheah
Journal:  Crit Rev Oncol Hematol       Date:  2008-09-06       Impact factor: 6.312

7.  Urologists' and GPs' knowledge of hereditary prostate cancer is suboptimal for prostate cancer counseling: a nation-wide survey in The Netherlands.

Authors:  Ruben Cremers; Christi van Asperen; Paul Kil; Hans Vasen; Tjerk Wiersma; Inge van Oort; Lambertus Kiemeney
Journal:  Fam Cancer       Date:  2012-06       Impact factor: 2.375

8.  Oncologists' opinions on genetic testing for breast and ovarian cancer.

Authors:  J O Culver; J L Hull; D F Dunne; W Burke
Journal:  Genet Med       Date:  2001 Mar-Apr       Impact factor: 8.822

9.  Deficiency of knowledge of genetics and genetic tests among general practitioners, gynecologists, and pediatricians: a global problem.

Authors:  Marieke J H Baars; Lidewij Henneman; Leo P Ten Kate
Journal:  Genet Med       Date:  2005 Nov-Dec       Impact factor: 8.822

10.  Swiss primary care physicians' knowledge, attitudes and perception towards genetic testing for hereditary breast cancer.

Authors:  Gabriella Pichert; Daniel Dietrich; Peter Moosmann; Marcel Zwahlen; Rolf Arno Stahel; André-Pascal Sappino
Journal:  Fam Cancer       Date:  2003       Impact factor: 2.446

View more
  13 in total

1.  Genetic cancer risk assessment in general practice: systematic review of tools available, clinician attitudes, and patient outcomes.

Authors:  Flore Laforest; Pia Kirkegaard; Baljinder Mann; Adrian Edwards
Journal:  Br J Gen Pract       Date:  2018-12-03       Impact factor: 5.386

2.  A family history questionnaire improves detection of women at risk for hereditary gynecologic cancer: a pilot study.

Authors:  Margot M Koeneman; Arnold-Jan Kruse; Simone J S Sep; Cynthia S Gubbels; Brigitte F M Slangen; Toon van Gorp; Alberto Lopes; Encarna Gomez-Garcia; Roy F P M Kruitwagen
Journal:  Fam Cancer       Date:  2014-09       Impact factor: 2.375

3.  Factors Associated with Interest in Gene-Panel Testing and Risk Communication Preferences in Women from BRCA1/2 Negative Families.

Authors:  Kristina G Flores; Laurie E Steffen; Christopher J McLouth; Belinda E Vicuña; Amanda Gammon; Wendy Kohlmann; Lucretia Vigil; Zoneddy R Dayao; Melanie E Royce; Anita Y Kinney
Journal:  J Genet Couns       Date:  2016-08-06       Impact factor: 2.537

4.  Differences in attitudes toward genetic testing among the public, patients, and health-care professionals in Korea.

Authors:  Heesang Eum; Mangyeong Lee; Junghee Yoon; Juhee Cho; Eun Sook Lee; Kui Son Choi; Sangwon Lee; So-Youn Jung; Myong Cheol Lim; Sun-Young Kong; Yoon Jung Chang
Journal:  Eur J Hum Genet       Date:  2018-06-18       Impact factor: 4.246

Review 5.  Clinical cancer genomic profiling.

Authors:  Debyani Chakravarty; David B Solit
Journal:  Nat Rev Genet       Date:  2021-03-24       Impact factor: 53.242

6.  Integrating Germline Genetics Into Precision Oncology Practice in the Veterans Health Administration: Challenges and Opportunities.

Authors:  Maren T Scheuner; Kenute Myrie; Jane Peredo; Lori Hoffman-Hogg; Margaret Lundquist; Stephanie L Guerra; Douglas Ball
Journal:  Fed Pract       Date:  2020-08

7.  The financial hazard of personalized medicine and supportive care.

Authors:  Pricivel M Carrera; Ian Olver
Journal:  Support Care Cancer       Date:  2015-08-27       Impact factor: 3.603

8.  The value of genetic testing: beyond clinical utility.

Authors:  Barbara Lerner; Nell Marshall; Sabine Oishi; Andrew Lanto; Martin Lee; Alison B Hamilton; Elizabeth M Yano; Maren T Scheuner
Journal:  Genet Med       Date:  2016-12-15       Impact factor: 8.822

9.  Genetic testing in a gynaecological oncology care in developing countries-knowledge, attitudes and perception of Nepalese clinicians.

Authors:  Hanoon P Pokharel; Neville F Hacker; Lesley Andrews
Journal:  Gynecol Oncol Res Pract       Date:  2016-12-05

10.  Genetics educational needs in China: physicians' experience and knowledge of genetic testing.

Authors:  Jing Li; Tengda Xu; Beverly M Yashar
Journal:  Genet Med       Date:  2014-12-11       Impact factor: 8.822

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.